EXAMINATION OF ANXIETY IN PREGNANT WOMEN DURING THE COVID-19 PANDEMIC

Öz

Objective: This study aimed to examine anxiety and related factors in pregnant women during the COVID-19 pandemic. Methods: This research has a cross-sectional, descriptive, and correlational design.The research was conducted on pregnant women who applied to the State Hospital and Family Health Centers in a city located in the south of Turkey between September 2021 and May 2022. The sample size was calculated as 311 pregnant women by G-Power analysis. The Socio-Demographic Characteristics Form, Epidemic Disease Anxiety Scale, and COVID-19 Anxiety, Scale were used in data collection. In the analysis of data; Descriptive statistics, T-test, Anova, Correlation, and Process Macro were used to analyze the regulatory impact. Results: The mean age of the pregnant women was 28.90±5.13. 44% of the pregnant women are high school graduates and 64% have a middle-income level. The mean number of pregnancies was 2.28±1.18 and the gestational week was 23.81±7.58. 79.4% of pregnancies were planned. 43.4% of pregnant women were previously diagnosed with COVID-19. 38.6% of the participants stated that they experienced anxiety due to epidemic anxiety and 36.7% of them stated that they experienced anxiety due to COVID-19. A correlation was calculated between the Epidemic Anxiety Scale score and the COVID-19 Anxiety Scale score (r=0.322, p<0.01). Epidemic Disease Anxiety Scale mean score is 40.68±11.92, COVID-19 Anxiety Scale mean score is 6.60±2.60. In the relationship between epidemic disease anxiety and COVID-19 anxiety, planned pregnancy (β=0.0825, 95%CI [.0201, .1449] and anxiety due to epidemic (β=-0.0597, 95%CI [-.1128, -. 0065] was calculated to have a regulatory effect. Conclusion: In the relationship between the anxiety of epidemic disease and anxiety of COVID-19, the planned pregnancy and the state of experiencing anxiety due to the epidemic are in the role of the rheostat.

Anahtar Kelimeler

• Anxiety
• regulatory effect
• pregnancy
• epidemic anxiety

Covid-19 Salgınında Gebelerde Anksiyetenin İncelenmesi

Öz

Amaç: Bu çalışma, COVID-19 pandemisi sırasında gebe kadınlarda anksiyete ve ilişkili faktörleri incelemeyi amaçlamıştır. Yöntemler: Bu araştırma kesitsel, tanımlayıcı ve ilişki arayıcı tasarımdadır Araştırma Eylül 2021 - Mayıs 2022 tarihleri arasında, Türkiye’nin güneyinde yer alan bir şehirde Devlet Hastanesine ve Aile Sağlığı Merkezlerine başvuran gebelerde yapılmıştır. Örneklem büyüklüğü G-Power analizi ile 311 gebe olarak hesaplanmıştır. Veri toplamada; Sosyo-Demografik Özellikler Formu, Salgın Hastalık Kaygı Ölçeği ve COVID-19 Anksiyete Ölçeği kullanılmıştır. Verilerin analizinde; tanımlayıcı istatistikler, T-testi, Anova, Korelasyon ve Process Macro ile düzenleyici etki incelemesi yapılmıştır. Bulgular: Gebelerin yaş ortalaması 28,90±5,13 dür. Gebelerin %44’ü lise mezunu olup %64’ü orta gelir düzeyine sahiptir. Gebelik sayısı ortalaması 2,28±1,18 ve gebelik haftası 23,81±7,58 dir. Gebeliklerin %79,4’ü planlı gerçekleşmiştir. Gebelerin %43.4’ü daha önce COVID-19 tanısı almıştır. Katılımcıların %38,6’sı salgın kaygısı, %36,7’si COVID-19 nedeniyle anksiyete yaşadığını ifade etmektedir. Salgın Hastalık Kaygı Ölçeği puanı ile COVID-19 Anksiyete Ölçek puanı arasında korelasyon hesaplanmıştır (r=0,322, p<0,01). Salgın Hastalık Kaygı Ölçeği puan ortalaması 40,68±11,92, COVID-19 Anksiyete Ölçek puan ortalaması 6,60±2,60 dır. Salgın hastalık kaygısı ile COVID-19 anksiyetesi arasındaki ilişkide gebeliğin planlı olması (β=0,0825, 95%CI [.0201, .1449] ve salgın nedeniyle kaygı yaşama durumunun (β=-0.0597, 95%CI [-.1128, -.0065]düzenleyici etkisi olduğu hesaplanmıştır. Sonuç: Salgın hastalık kaygısı ile COVID-19 anksiyetesi arasındaki ilişkide gebeliğin planlı olması ve salgın nedeniyle kaygı yaşama durumu reosta görevindedir.

Anahtar Kelimeler

• Anksiyete
• düzenleyici etki
• gebe
• salgın kaygısı

Kaynakça

1. Zarulli V, Barthold Jones JA, Oksuzyan A, Lindahl-Jacobsen R, Christensen K, Vaupel JW. Women live longer than men even during severe famines and epidemics. Proc Natl Acad Sci U S A. 2018;115(4):E832–40.
2. Evcili F, Demirel G. Covid-19 Pandemisi’nin kadın sağlığına etkileri ve öneriler üzerine bir değerlendirme. Türk Fen ve Sağlık Derg. 2020;1(2):1–2.
3. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–27.
4. Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen J-P, et al. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. J Clin Med. 2020;9(3):623.
5. Luo M, Guo L, Yu M, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public: A systematic review and meta-analysis. Psychiatry Res. 2020;291:113190.
6. De Sousa A, Mohandas E, Javed A. Psychological interventions during COVID-19: Challenges for low and middle income countries. Asian J Psychiatr. 2020;51:102128.
7. Chen Y, Li Z, Zhang YY, Zhao WH, Yu ZY. Maternal health care management during the outbreak of coronavirus disease 2019. J Med Virol. 2020;92(7):731–9.
8. Milne SJ, Corbett GA, Hehir MP, Lindow SW, Mohan S, Reagu S, et al. Effects of isolation on mood and relationships in pregnant women during the COVID-19 pandemic. J Clean Prod. 2020;252:610–1.

9. Lebel C, MacKinnon A, Bagshawe M, Tomfohr-Madsen L, Giesbrecht G. Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic. J Affect Disord. 2020;277:5–13.
10. Saccone G, Florio A, Aiello F, Venturella R, De Angelis MC, Locci M, et al. Psychological impact of coronavirus disease 2019 in pregnant women. Am J Obstet Gynecol. 2020;223(2):293–5.
11. Durankuş F, Aksu E. Effects of the COVID-19 pandemic on anxiety and depressive symptoms in pregnant women: A preliminary study. J Matern Fetal Neonatal Med. 2020;1–7.
12. Corbett GA, Milne SJ, Hehir MP, Lindow SW, O’Connell MP. Health anxiety and behavioural changes of pregnant women during the COVID-19 pandemic. Eur J Obstet Gynecol Reprod Biol. 2020;249:96–7.
13. Zanardo V, Manghina V, Giliberti L, Vettore M, Severino L, Straface G. Psychological impact of COVID-19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period. Int J Gynaecol Obstet. 2020;150(2):184–8.
14. Thapa SB, Mainali A, Schwank SE, Acharya G. Maternal mental health in the time of the COVID-19 pandemic. Acta Obstet Gynecol Scand. 2020;99(7):817–8.
15. Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017;219:86–92.
16. Bussières EL, Tarabulsy GM, Pearson J, Tessier R, Forest JC, Giguère Y. Maternal prenatal stress and infant birth weight and gestational age: A meta-analysis of prospective studies. Dev Rev. 2015;36:179–99.
17. Meaney MJ. Perinatal maternal depressive symptoms as an issue for population health. Am J Psychiatry. 2018;175(11):1084–93.
18. Berthelot N, Lemieux R, Garon-Bissonnette J, Drouin-Maziade C, Martel É, Maziade M. Uptrend in distress and psychiatric symptomatology in pregnant women during the coronavirus disease 2019 pandemic. Acta Obstet Gynecol Scand. 2020;99(7):848–55.
19. Moyer CA, Compton SD, Kaselitz E, Muzik M. Pregnancy-related anxiety during COVID-19: A nationwide survey of 2740 pregnant women. Arch Womens Ment Health. 2020;23(6):757–65.
20. Nanjundaswamy MH, Shiva L, Desai G, Ganjekar S, Kishore T, Ram U, et al. COVID-19-related anxiety and concerns expressed by pregnant and postpartum women—a survey among obstetricians. Arch Womens Ment Health. 2020;23(6):787–90.
21. Grigoriadis S, Graves L, Peer M, Mamisashvili L, Tomlinson G, Vigod SN, et al. A systematic review and meta-analysis of the effects of antenatal anxiety on postpartum outcomes. Arch Womens Ment Health. 2019;22(5):543–56.
22. Noordam R, Aarts N, Verhamme KM, Sturkenboom MCM, Stricker BH, Visser LE. Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: A dynamic population-based study. Eur J Clin Pharmacol. 2015;71(3):369–75.
23. Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr. 2020;52:102066.
24. Büyüköztürk Ş, Kılıç Çakmak E, Akgün ÖE, Karadeniz Ş, Demirel F. Bilimsel Araştırma Yöntemleri. Ankara: Pegem Akademi; 2008.
25. Karasar N. Bilimsel Araştırma Yöntemleri. Ankara: Nobel Yayın; 2005.
26. Savaş M, Ödek Ö, Çelik H, Zincir H. Experiences of nurses diagnosed with COVID-19: A qualitative study. J Caring Sci. 2024;13(3):180–7.
27. Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Stud. 2020;44(7):393–401.
28. Biçer İ, Çakmak C, Demir H. Coronavirus Anxiety Scale Short Form: Turkish validity and reliability study. Anadolu Klin Tıp Bilim Derg. 2020;25:216–25.
29. Hızlı Sayar G, Ünübol H, Ünal AT, Tarhan N. Salgın Hastalık Kaygı Ölçeği: Geçerlilik ve Güvenirlik Çalışması. Curr Approaches Psychiatry. 2020;12:1–10.
30. Mortazavi F, Mehrabad M, KiaeeTabar R. Pregnant women’s well-being and worry during the COVID-19 pandemic: A comparative study. BMC Pregnancy Childbirth. 2021;21:4.
31. Mei H, Li N, Li J, Zhang D, Cao Z, Zhou Y, et al. Depression, anxiety, and stress symptoms in pregnant women before and during the COVID-19 pandemic. J Psychosom Res. 2021;149:110–7.
32. Esteban-Gonzalo S, Caballero-Galilea M, González-Pascual JL, Álvaro-Navidad M, Esteban-Gonzalo L. Anxiety and worries among pregnant women during the COVID-19 pandemic: A multilevel analysis. Int J Environ Res Public Health. 2021;18(13):1–15.
33. Dong H, Hu R, Lu C, Huang D, Cui D, Huang G, et al. Investigation on the mental health status of pregnant women in China during the pandemic of COVID-19. Arch Gynecol Obstet. 2021;303(2):463–9.
34. Zhou Y, Shi H, Liu Z, Peng S, Wang R, Qi L, et al. Prevalence of psychiatric symptoms of pregnant and non-pregnant women during the COVID-19 epidemic. Transl Psychiatry. 2020;10(1):1–7.
35. Wu F, Lin W, Liu P, Zhang M, Huang S, Chen C, et al. Prevalence and contributory factors of anxiety and depression among pregnant women in the post-pandemic era of COVID-19 in Shenzhen, China. J Affect Disord. 2021;291:243–51.
36. Luo Y, Zhang K, Huang M, Qiu C. Risk factors for depression and anxiety in pregnant women during the COVID-19 pandemic: Evidence from meta-analysis. PLoS One. 2022;17(3):e0265021.
37. London V, McLaren R, Atallah F, Cepeda C, McCalla S, Fisher N, et al. The relationship between status at presentation and outcomes among pregnant women with COVID-19. Am J Perinatol. 2020;37(10):991–4.
38. Banaei M, Ghasemi V, Saei M, Naz G, Kiani Z, Rashidifakari F, et al. Obstetrics and neonatal outcomes in pregnant women with COVID-19: A systematic review. Iran J Public Health. 2020;49:38–47.